Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors

Glioblastoma multiforme (GBM) remains refractory to conventional therapy. CD133+ GBM cells have been recently isolated and characterized as chemo-/radio-resistant tumor-initiating cells and are hypothesized to be responsible for post-treatment recurrence. In order to explore the molecular properties...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qinghai, Nguyen, David H., Dong, Qinghua, Shitaku, Peter, Chung, Kenneth, Liu, On Ying, Tso, Jonathan L., Liu, Jason Y., Konkankit, Veerauo, Cloughesy, Timothy F., Mischel, Paul S., Lane, Timothy F., Liau, Linda M., Nelson, Stanley F., Tso, Cho-Lea
Formato: Texto
Lenguaje:English
Publicado: Springer US 2009
Materias:
Priority Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705704/
https://www.ncbi.nlm.nih.gov/pubmed/19468690
http://dx.doi.org/10.1007/s11060-009-9919-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705704/
https://www.ncbi.nlm.nih.gov/pubmed/19468690
http://dx.doi.org/10.1007/s11060-009-9919-z

Ejemplares similares